Beijing Inno Medicine Co., Ltd.
Clinical trials sponsored by Beijing Inno Medicine Co., Ltd., explained in plain language.
-
New drug aims to shrink heart artery blockages
Disease control Recruiting nowThis study tests a new medicine called YN001 in 24 adults with coronary atherosclerosis (plaque buildup in heart arteries). Participants receive YN001 by IV along with a standard cholesterol-lowering drug. The goal is to see if YN001 can reduce plaque volume and improve artery he…
Phase: PHASE2 • Sponsor: Beijing Inno Medicine Co., Ltd. • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
New drug YN001 tested in healthy volunteers for safety and body processing
Knowledge-focused Recruiting nowThis early-stage study tests a new drug called YN001 in 24 healthy adults aged 18 to 65. Researchers will measure how the drug moves through the body and check for side effects. The goal is to gather basic safety and drug-level information, not to treat any disease.
Phase: PHASE1 • Sponsor: Beijing Inno Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated May 17, 2026 05:32 UTC